tiprankstipranks
Trending News
More News >
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
US Market

Lisata Therapeutics (LSTA) Income Statement

Compare
1,049 Followers

Lisata Therapeutics Income Statement

Last quarter (Q3 2025), Lisata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lisata Therapeutics's net income was $-4.25M. See Lisata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.00M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 1.00M$ 0.00$ 0.00$ 0.00$ -63.00K
Operating Expenses
$ 23.41M$ 25.71M$ 57.60M$ 29.05M$ 19.14M
Depreciation and Amortization
$ 174.00K$ 189.00K$ 69.00K$ 55.00K$ 63.00K
EBITDA
$ -22.23M$ -25.52M$ -57.53M$ -29.00M$ -19.08M
Operating Income
$ -22.41M$ -25.71M$ -57.60M$ -29.05M$ -19.14M
Other Income/Expenses
$ 1.63M$ 2.54M$ 897.00K$ 76.00K$ 132.00K
Pretax Income
$ -20.78M$ -23.17M$ -56.70M$ -28.97M$ -19.01M
Net Income
$ -19.98M$ -20.84M$ -54.23M$ -27.47M$ -8.15M
Per Share Metrics
Basic EPS
$ -2.40$ -2.58$ -10.47$ -7.45$ -7.91
Diluted EPS
$ -2.40$ -2.58$ -10.47$ -7.45$ -7.91
Weighted Average Shares Outstanding
8.33M 8.07M 5.18M 3.69M 1.03M
Weighted Average Shares Outstanding (Diluted)
8.33M 8.07M 5.18M 3.69M 1.03M
Currency in USD

Lisata Therapeutics Earnings and Revenue History